China County Health Conference: Wu Yiling academician team of Chinese medicine research and innovation results to help the prevention and treatment of primary-level chronic diseases.

From September 4th to 6th, the China County Health Conference was held in Suzhou, and the leaders of the relevant departments of the National Health and Health Commission, academicians from various disciplines and managers of county hospitals attended the guidance meeting.
Professor Wu Yiling, a member of the Chinese Academy of Engineering, gave a keynote speech entitled "Research and Translational Medicine" at the main forum of the General Assembly, which has a profound impact on improving the service capacity of chinese medicine at the grass-roots level and the prevention and treatment of chronic diseases.
Professor Wu Yiling, a member of the Chinese Academy of Engineering, made a keynote report entitled "Research and Translational Medicine" at the main forum of the General Assembly on Chinese medicine on the world stage in recent years, Wu Yiling academician led a team of experts in chinese medicine, Western medicine, Chinese and Western medicine to inherit innovative Chinese medicine culture, and systematically build a network of diseases The theoretical system, the creation of the "theory, clinical, new drugs, experiments and evidence-based" integration of Chinese medicine academic innovation and transformation of new models, traditional Chinese medicine theory innovation and modern science and technology combined to produce major original results, won six national science and technology awards, for the Chinese medicine heritage and innovation and development has made a model.
capsules/particles, which play an important role in the fight against new crowns, A-streams and SARS, are innovative Chinese medicines developed based on the theory of disease.
even the plague in modern pharmacological research, clinical applications have also proved its importance, in the treatment of influenza research won the 2011 National Science and Technology Progress Award.
Since the outbreak of neo-crown pneumonia, Lianhua Qing plague capsules (particles) have been jointly issued by the National Health And Wellness Commission and the State Administration of Traditional Chinese Medicine, "new coronavirus pneumonia diagnosis and treatment program" (trial 4/5/6/7/8 edition) and more than 20 provinces and cities of the new coronary pneumonia diagnosis and treatment program recommended, become the most frequently recommended Traditional Chinese medicine.
April 2020, China's State Drug Administration approved Lianhua Qing plague capsules/particles to add a new adaptive "new coronavirus pneumonia light, common type" on the basis of the original approved adaptation.
the outbreak, Lianhua Qing plague was widely used in hospitals for patients with neo-coronary pneumonia.
studies have shown that lianhuasin plague can significantly inhibit the replication of new coronavirus in cells, resulting in a significant reduction in in-cell viral particle expression.
The results of the forward-looking, randomized, controlled and multi-center clinical study on the treatment of new coronavirus pneumonia by Zhong Nanshan, Li Lanxuan, Zhang Boli and other experts, jointly participating in more than 20 hospitals, were published in The Journal of Plant Medicine, which has a higher impact factor in the field of international botany.
the study found that the treatment of new coronavirus pneumonia on the basis of conventional treatment is safe and effective, can significantly improve the rate of improvement of new coronary pneumonia fever, fatigue, cough and other clinical symptoms, significantly improve lung imaging lesions, shorten the duration of symptoms, improve the clinical cure rate.
not only that, Lianhua Qing plague also as a Chinese medicine "class representative" out of the country, on the world stage to make a strong voice, the international market demand multiplied, for the global epidemic prevention and control played an important role.
The research and innovation of Chinese medicine network disease to crack the grass-roots slow disease problem not only uses the theory of network disease to guide external thermothermal fever, Wu Yiling led the team for the first time to systematically build the theory of Chinese medicine veins to guide the prevention and treatment of microvascular disease major original theory, to solve the problem of cardiovascular disease.
"Construction of China's Vein Theology and Its Guidance for the Prevention and Control of Microvascular Lesions" project won the first prize of the 2019 National Science and Technology Progress Award, which is also the only national science and technology progress first prize in the field of life science in 2019.
Wu Yiling academician team under the guidance of the theory of the disease developed a treatment of cardiovascular and cerebrovascular disease, integrated regulation, fast and slow treatment of arrhythmic ginseng heart capsules, treatment of chronic heart failure of thestrong heart capsules, treatment A series of innovative Chinese medicines with independent intellectual property rights, such as colds, flu, and new crowns, have been widely used in clinical practice, improving the level of diagnosis and treatment of clinically incurable diseases such as cardiovascular disease, diabetes, breathing, tumors, etc., and also solving the difficult problem of primary chronic disease prevention and treatment.
more than 2,000 academician experts from all over the country, health administrative departments, medical and health agency managers, doctors and so on came to the scene, a grand event.
statistics, the county population accounts for 62% of China's population, the number of county population as many as 900 million.
the current national county-level hospitals about 6000, in accordance with the requirements of the national classification system, these county-level hospitals will assume 90% of the county clinical diagnosis and treatment tasks.
, it is of great significance to apply the theoretical achievements of Chinese medicine innovation to clinical practice and improve the capacity of county medical services to realize the strategy of healthy China.
source: MedSci Originals !-- content presentation ends -- !-- to determine whether the login ends.